Using deep learning to improve vancomycin treatment monitoring
Deep Learning Based Pharmacokinetic Model for Vancomycin
This study is looking to improve how doctors monitor the antibiotic vancomycin by using advanced technology to create personalized treatment plans, especially for patients dealing with tough infections like MRSA.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10933564 on NIH RePORTER |
What this research studies
This research focuses on enhancing the monitoring of vancomycin, a commonly used antibiotic, through advanced deep learning techniques. By utilizing real-world electronic health records, the study aims to develop a more accurate pharmacokinetic model that can better predict drug concentrations in individual patients. The approach involves creating a deep-learning model that incorporates a wide range of patient-specific data, allowing for more personalized treatment plans. This could lead to improved management of vancomycin therapy, particularly for patients with infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
Who could benefit from this research
Good fit: Ideal candidates for this research include patients receiving vancomycin treatment, especially those with MRSA infections.
Not a fit: Patients who are not being treated with vancomycin or those with infections not caused by MRSA may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer vancomycin treatments, reducing the risk of toxicity while ensuring the drug's efficacy.
How similar studies have performed: Other research has shown promise in using deep learning for pharmacokinetic modeling, indicating that this approach could be a significant advancement in the field.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Nigo, Masayuki — Methodist Hospital Research Institute
- Study coordinator: Nigo, Masayuki
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.